+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Withdrawn

Phase 1
All Ages
All Genders
ID00000199

Piracetam for Treatment of Cocaine Addiction, Phase II

Led by University of Pennsylvania · Updated on 2017-03-30

N/A

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

The purpose of this study is to follow patients in Phase I of an inpatient study in an eight week open label assessment of piracetam in an outpatient treatment program.

CONDITIONS

Brief Title

Piracetam for Treatment of Cocaine Addiction, Phase II - 4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here